(Updated - August 19, 2026 1:40 PM EDT)

BofA Securities analyst Alec Stranahan upgraded Moderna (NASDAQ: MRNA) from Underperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE